Welcome Amanda M. McClure, MD

Please join us in welcoming Amanda M. McClure, MD, to IHA Colon & Rectal Surgery. Dr. McClure has clinical interests in the prevention, diagnosis and treatment of colorectal cancer. Dr. McClure specializes in treating diverticulitis, inflammatory bowel disease and anorectal disorders including hemorrhoids, fissures, abscesses and fistulas.She performs specialized testing and treatment for pelvic floor disorders, including constipation and fecal incontinence.





Health Alert: Voluntary Recall of Children’s Cough Syrup

The Perrigo Company is voluntarily recalling two batches of its children’s Guaifenesin grape liquid (100mg/5 mL) and three batches of its children’s Guaifenesin DM cherry liquid (100mg guaifenesin and 5mg dextromethorphan HBr/ 5 ml) after a dosing cup with the wrong markings was included with the 4 oz. bottles. The medications are sold at nine major stores under different brand names across the country. (See below for a full list)

The U.S. Food and Drug Administration (FDA) is aware of the recall. A company statement says that using these recalled products “according to labeled instructions with an affected dosing cup is unlikely to result in serious side effects”, and it says that there have been no reports of anyone becoming sick.

“There have been no reports of adverse events to Perrigo as a result of the incorrect dosage markings,” Perrigo’s Chairman and CEO Joseph C. Papa said in a statement. “Perrigo is taking this action to maintain the highest possible product quality standards for our retail customers and consumers. We are taking this action because it is the right thing to do.”

Recalled lots, along with their corresponding branded labels, are listed below:


H.E.B 5LK0592 08/2017
CVS 5MK0340 5MK0340


 Sunmark  5LK0528, 5LK0630   03/2017
 Rite-Aid   5LK0528, 5LK0630  03/2017
 Topcare  5LK0528, 5LK0630, 5LK0779   03/2017
 Kroger  5LK0528, 5LK0630   03/2017
 GoodSense   5LK0528   03/2017
 Dollar General   5LK0630   03/2017
 Care One   5LK0630   03/2017
 CVS  5LK0630   03/2017

 Click here for more information.

IHA Physicians Named Best Doctors for 2015-2016

IHA is pleased to announce 53 of our physicians were named Best Doctors in America® for 2015-2016. The highly regarded Best Doctors in America® List, assembled by Best Doctors, Inc. and audited and certified by Gallup, results from exhaustive polling of over 45,000 physicians in the U.S. Only those doctors recognized as the top 5 percent of their respective specialty earn the honor of being named one of the Best Doctors in America. Click here to see the entire list.

IHA Partners with Zipnosis to Launch a New Game-Changing Virtual Care Service

IHA Partners with Zipnosis to Launch a New Game-Changing Virtual Care Service
Safe, Fast and Affordable Online Diagnosis Coming to Michigan

10/5/2015 – IHA, one of Michigan’s most recognized multi-specialty physician groups, will soon launch a profoundly simple online diagnosis and treatment service for people with straightforward health problems in the Michigan area. This service will connect patients to IHA clinicians online to receive prompt, high-quality virtual care for common medical conditions, such as sinus infections, female bladder infections, pink eye, colds and flu—all for a flat fee payable online.

“Through our partnership with Zipnosis, we are excited to give more patients what they want—fast, affordable access to mainstream medicine in minutes,” said Jason Harris, IHA’s Vice President for Planning and Development. “Starting in early 2016, the Zipnosis platform will allow us to make high quality care from our own clinicians available to patients where and when they want to receive it, at an affordable price.”

“This is an exciting collaboration for Zipnosis,” says Jon Pearce, CEO and co-founder of Zipnosis. “Zipnosis is grateful to have the opportunity to support IHA’s in delivering convenient, affordable healthcare in Michigan. By using our advanced virtual care platform, IHA’s clinicians will be more efficient in providing care while simultaneously delighting patients with the most accessible healthcare in the country.”

Designed on the premise of quality care above all else, Zipnosis is continuing to improve patient care one click at a time – beating urgent care compliance to CDC’s clinical guidelines for many of the conditions it treats. In fact, adherence to evidence-based guidelines via the Zipnosis platform is 98.4 percent for sinusitis and nearly 100 percent for UTI, while the average for urgent care centers is 70 percent.

IHA is one of the best and largest multi-specialty groups in Michigan. IHA employs more than 1,600 staff members, which includes 450 providers consisting of: physicians, nurse practitioners, physician assistants and midwives across nearly 60 practices in southeast Michigan. IHA provides high-quality medical care and excellent service to more than 355,000 active patients. Recognized as one of Michigan’s top performing medical groups, IHA also ranks in the top quartile for patient satisfaction nationally. Offering extended office hours, Urgent Care, and access to clinical research studies, IHA demonstrates that it cares by bringing safe, high-quality, comprehensive and affordable care to its patients. For more information about IHA, visit www.ihacares.com.

Founded in 2008, privately-held Zipnosis is the first virtual care solution to empower health care systems with the technology and methodology to launch their own virtual care service line in a profoundly fast and simple way. The proven-in-use, best practice-based methodology ensures health system-wide engagement, while the asynchronous, adaptive assessment software offers patients modern-day access and convenience, while significantly reducing the clinical time required to safely diagnose, treat or triage more than 90 minor medical conditions.

The unique health system brand extension approach enables a branded, digital access point to attract more patients to the care they need and ensures in-system care quality and continuity from the health system’s clinicians and triage points. Visit www.zipnosis.com, LinkedIn, Facebook and Twitter to learn more.